- Home
- BRAG vs GNTA Comparison
BRAG vs GNTA Comparison
Compare BRAG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRAG | GNTA |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | Canada | Italy |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.3M | 34.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BRAG | GNTA |
|---|---|---|
| Price | $2.00 | $1.41 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 32.0K | ★ 91.5K |
| Earning Date | 11-13-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $123,839,024.00 | N/A |
| Revenue This Year | $6.68 | N/A |
| Revenue Next Year | $1.90 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.49 | N/A |
| 52 Week Low | $1.95 | $1.28 |
| 52 Week High | $6.12 | $10.00 |
Technical Indicators
Market Signals| Indicator | BRAG | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 35.63 | 34.68 |
| Support Level | $1.95 | $1.28 |
| Resistance Level | $2.21 | $1.68 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 14.71 | 21.08 |
Price Performance
Historical ComparisonAbout BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.